Skip to content
  • Tuesday, 30 June 2026
  • 2:14 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Deloitte report showed pharma returns rising to 7%. GLP-1s did most of the work.
Laboratory Automation & Robotics

Deloitte report showed pharma returns rising to 7%. GLP-1s did most of the work.

Lana Keisha May 28, 2026 0

After a period of post-pandemic uncertainty and uneven growth, a closely monitored metric of biopharmaceutical research and development (R&D) productivity…

Read More
Laboratory Automation & Robotics

Deloitte report showed pharma returns rising to 7%. GLP-1s did most of the work.

Lana Keisha May 14, 2026 0

The pharmaceutical industry, emerging from a period characterized by uneven growth and significant challenges in research and development (R&D) productivity,…

Read More
The Proof in the Code Chronicles the Algorithmic Ascent in MathematicsMachine Learning Framework Unveils Hidden Physical Laws of Non-Reciprocal Forces in Complex Dusty Plasma SystemsOpenAI Codex Revolutionizes Software Development with Five Demonstrative Projects Showcasing AI’s Practical Application Across Diverse Fields.Precision Synthesis Method Unlocks Unprecedented Electrical Performance in MXene Nanomaterials through Atomic Surface Control
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in SpermPens to pills: what oral GLP-1s change at the benchArc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s DiseaseTalawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in Sperm
Dwi Wanna Jun 30, 2026
Laboratory Automation & Robotics
Pens to pills: what oral GLP-1s change at the bench
Lana Keisha Jun 30, 2026
Neuroscience & Brain Research
Arc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s Disease
Rifan Muazin Jun 30, 2026
Pharmaceutical R&D
Talawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
Teuku Ryan Jun 30, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ